|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liaw YF, Kao JH, Piratvisuth T, Chan HL,
Chien RN, Liu CJ, Gane E, Locarnini S, Lim SG, Han KH, et al:
Asian-Pacific consensus statement on the management of chronic
hepatitis B: A 2012 update. Hepatol Int. 6:531–561. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu GQ, Shi KQ, Yu HJ, He SY, Braddock M,
Zhou MT, Chen YP and Zheng MH: Optimal adjuvant therapy for
resected hepatocellular carcinoma: A systematic review with network
meta-analysis. Oncotarget. 6:18151–18161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Lau WB, Snel B and Clevers HC: The
R-spondin protein family. Genome Biol. 13:2422012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nam JS, Turcotte TJ and Yoon JK: Dynamic
expression of R-spondin family genes in mouse development. Gene
Expr Patterns. 7:306–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parma P, Radi O, Vidal V, Chaboissier MC,
Dellambra E, Valentini S, Guerra L, Schedl A and Camerino G:
R-spondin1 is essential in sex determination, skin differentiation
and malignancy. Nat Genet. 38:1304–1309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bell SM, Schreiner CM, Wert SE, Mucenski
ML, Scott WJ and Whitsett JA: R-spondin 2 is required for normal
laryngeal-tracheal, lung and limb morphogenesis. Development.
135:1049–1058. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aoki M, Mieda M, Ikeda T, Hamada Y,
Nakamura H and Okamoto H: R-spondin3 is required for mouse
placental development. Dev Biol. 301:218–226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khan TN, Klar J, Nawaz S, Jameel M, Tariq
M, Malik NA, Baig SM and Dahl N: Novel missense mutation in the
RSPO4 gene in congenital hyponychia and evidence for a polymorphic
initiation codon (p.M1I). BMC Med Genet. 13:1202012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lowther W, Wiley K, Smith GH and Callahan
R: A new common integration site, Int7, for the mouse mammary tumor
virus in mouse mammary tumors identifies a gene whose product has
furin-like and thrombospondin-like sequences. J Virol.
79:10093–10096. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Theodorou V, Kimm MA, Boer M, Wessels L,
Theelen W, Jonkers J and Hilkens J: MMTV insertional mutagenesis
identifies genes, gene families and pathways involved in mammary
cancer. Nat Genet. 39:759–769. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim KA, Kakitani M, Zhao J, Oshima T, Tang
T, Binnerts M, Liu Y, Boyle B, Park E, Emtage P, et al: Mitogenic
influence of human R-spondin1 on the intestinal epithelium.
Science. 309:1256–1259. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seshagiri S, Stawiski EW, Durinck S,
Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman
V, Jaiswal BS, et al: Recurrent R-spondin fusions in colon cancer.
Nature. 488:660–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shinmura K, Kahyo T, Kato H, Igarashi H,
Matsuura S, Nakamura S, Kurachi K, Nakamura T, Ogawa H, Funai K, et
al: RSPO fusion transcripts in colorectal cancer in Japanese
population. Mol Biol Rep. 41:5375–5384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim KA, Wagle M, Tran K, Zhan X, Dixon MA,
Liu S, Gros D, Korver W, Yonkovich S, Tomasevic N, et al:
R-Spondins family members regulate the Wnt pathway by a common
mechanism. Mol Biol Cell. 19:2588–2596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huch M, Dorrell C, Boj SF, van Es JH, Li
VS, van de Wetering M, Sato T, Hamer K, Sasaki N, Finegold MJ, et
al: In vitro expansion of single Lgr5+ liver stem cells induced by
Wnt-driven regeneration. Nature. 494:247–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carmon KS, Gong X, Yi J, Thomas A and Liu
Q: RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling. Proc
Natl Acad Sci USA. 111:pp. E1221–E1229. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monga SP: β-Catenin signaling and roles in
liver homeostasis, injury and tumorigenesis. Gastroenterology.
148:1294–1310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gregorieff A, Liu Y, Inanlou MR, Khomchuk
Y and Wrana JL: Yap-dependent reprogramming of Lgr5(+) stem cells
drives intestinal regeneration and cancer. Nature. 526:715–718.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu T and Li C: Convergence between
Wnt-β-catenin and EGFR signaling in cancer. Mol Cancer. 9:2362010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahn SM, Jang SJ, Shim JH, Kim D, Hong SM,
Sung CO, Baek D, Haq F, Ansari AA, Lee SY, et al: Genomic portrait
of resectable hepatocellular carcinomas: Implications of RB1 and
FGF19 aberrations for patient stratification. Hepatology.
60:1972–1982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kononen J, Bubendorf L, Kallioniemi A,
Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G
and Kallioniemi OP: Tissue microarrays for high-throughput
molecular profiling of tumor specimens. Nat Med. 4:844–847. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boseman FT, Carneiro F, Hruban RH and
Theise ND: Tumours of the liver and intrahepatic bile ductsWorld
Health Organization Classification of Tumours of the Digestive
System. 4th. IARC; Lyon: pp. 195–262. 2010
|
|
28
|
Kang N, Gores GJ and Shah VH: Hepatic
stellate cells: Partners in crime for liver metastases? Hepatology.
54:707–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Coulouarn C and Clément B: Stellate cells
and the development of liver cancer: Therapeutic potential of
targeting the stroma. J Hepatol. 60:1306–1309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xinguang Y, Huixing Y, Xiaowei W, Xiaojun
W and Linghua Y: R-spondin1 arguments hepatic fibrogenesis in vivo
and in vitro. J Surg Res. 193:598–605. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yin X, Yi H, Wu W, Shu J, Wu X and Yu L:
R-spondin2 activates hepatic stellate cells and promotes liver
fibrosis. Dig Dis Sci. 59:2452–3961. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chartier C, Raval J, Axelrod F, Bond C,
Cain J, Dee-Hoskins C, Ma S, Fischer MM, Shah J, Wei J, et al:
Therapeutic targeting of tumor-derived R-spondin attenuates
β-catenin signaling and tumorigenesis in multiple cancer types.
Cancer Res. 76:713–722. 2016. View Article : Google Scholar : PubMed/NCBI
|
